Search
Now showing items 1-5 of 5
Acceptability of human immunodeficiency virus testing in patients with invasive cervical cancer in Kenya
(2005)
Invasive cervical cancer (ICC) is common in areas where human immunodeficiency virus (HIV) is also prevalent. Currently, HIV seroprevalence as well as acceptability of HIV testing in ICC patients in Kenya is unknown. The ...
HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancer
(2005)
To determine the impact of HIV infection on acute morbidity and pelvic tumor control following external beam radiotherapy (EBRT) for cervical cancer.
METHOD:
218 patients receiving EBRT who also had HIV testing after ...
Knowledge and Practice about cervical cancer and papsmear testing among patients at Kenyatta National Hospital, Nairobi, Kenya
(2006)
Invasive cervical cancer (ICC) is the leading cause of cancer-related death among women in developing countries. Population-based cytologic screening and early treatment does reduce morbidity and mortality associated with ...
HIV and cervical cancer in Kenya
(2002)
OBJECTIVES:
To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya.
METHODS:
Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) ...
Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya
(University of Nairobi., 2003-12)
Invasive cervical cancer (ICC) is the leading cause of cancer-related death among women in developing countries. Population-based cytologic screening and early treatment does reduce morbidity and mortality associated with ...